Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.004 Å; R factor = 0.054; wR factor = 0.200; data-to-parameter ratio = 13.9.
Related literature
For the biological activity of heterocyclic compounds, see: Gilchrist (1998) . For the bioactivity of pyrimidine derivatives, see: Xue et al. (1993) . For a related structure, see : Hemamalini et al. (2005) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data 
Data collection
Bruker SMART CCD diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996) T min = 0. Table 1 Hydrogen-bond geometry (Å , ). (Gilchrist, 1998) . As useful precursors to potentially bioactive pyrimidine derivatives, methylpyrimidine has attracted considerable attention for many years (Xue et al., 1993) . In recent years, new complexes of pyrimidine have been synthesized (Hemamalini et al., 2005) . Herein we report herein the crystal structure of the title compound (I).
The molecular structure of (I) is shown in Fig. 1 . There is one cation and one anion in the asymmetric unit of (I). All bond lengths are within the normal ranges (Allen et al., 1987) . In the crystal, two cations and two anions are linked by intermolecular N-H···O hydrogen bonds to form centrosymmetric four component aggregates.
Experimental
A mixture of 2-amino-4,6-dichloropyrimidine (0.1 mol) and sodium methoxide (0.1 mol) was stirred with methanol (30 ml) for 3 h to afford 2-Amino-4,6-dimethoxypyrimidine (yield 85%). The title compound was crystallized from an aqueous mixture containing 2-Amino-4,6-dimethoxypyrimidine and dichloroacetate in a 1:1 stoichiometric ratio at room temperature by the slow evaporation technique.
Refinement
H atoms bonded to C atoms were fixed geometrically and and included in a riding-model approximation with C-H = 0.93-0.98 Å and N-H = 0.86Å with U iso (H)=1.2-1.5U eq (C).
Computing details
Data collection: SMART (Bruker, 1997 ); cell refinement: SAINT (Bruker, 1997) ; data reduction: SAINT (Bruker, 1997);  program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009) ; software used to prepare material for publication: SHELXTL (Sheldrick, 2008 The structure of the title compound showing 30% probability displacement ellipsoids. 
